Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 55.92%-18.51K | 62.33%-16.68K | 67.35%-27.87K | -30.79%-155.41K | 284.69%16.21K | -42.76%-42K | -183.84%-44.28K | -31.24%-85.35K | 7.97%-118.83K | -236.23%-8.78K |
| Net income from continuing operations | -43.99%-26.03K | 81.46%-13.68K | 13.51%-18.35K | -839.32%-877.22K | -1,913.66%-764.1K | -44.48%-18.08K | -194.24%-73.82K | -18.92%-21.22K | 38.82%-93.39K | -8.84%-37.95K |
| Asset impairment expenditure | --1 | ---- | ---- | --719.9K | --719.9K | --0 | ---- | ---- | --0 | ---- |
| Change In working capital | 131.44%7.52K | -86.34%4.04K | 85.16%-9.52K | 107.50%1.91K | 107.15%60.42K | -41.50%-23.92K | 211.35%29.54K | -35.90%-64.13K | -155.27%-25.44K | -46.73%29.17K |
| -Change in receivables | -90.45%1.07K | -91.87%691 | 100.76%385 | -154.68%-2.66K | 17,423.75%28.04K | 974.07%11.22K | 3,582.79%8.5K | -1,389.29%-50.42K | 215.07%4.87K | 107.77%160 |
| -Change in prepaid assets | --0 | --0 | 106.72%914 | 97.01%-10 | -7.34%3.92K | 1.79%3.92K | 49.58%5.75K | -10.95%-13.59K | -497.62%-334 | -33.62%4.23K |
| -Change in payables and accrued expense | 116.51%6.45K | -78.13%3.34K | -9,144.44%-10.82K | 115.29%4.58K | 14.87%28.47K | -79.21%-39.06K | 159.77%15.29K | 99.70%-117 | -159.74%-29.98K | -50.88%24.78K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 56.48%-18.51K | 61.86%-16.68K | 67.35%-27.87K | -30.79%-155.41K | 284.69%16.21K | -44.60%-42.54K | -180.38%-43.74K | -31.24%-85.35K | 7.97%-118.83K | -236.23%-8.78K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -45.83%-3.5K | 136.47%7.03K | 0 | -2,214.81%-75.54K | -401.22%-50.12K | -125.33%-2.4K | -297.01%-19.28K | -141.77%-3.74K | 104.90%3.57K | 85.99%-10K |
| Net PPE purchase and sale | --0 | --0 | --0 | -299.10%-75.54K | -401.22%-50.12K | -125.33%-2.4K | -297.01%-19.28K | 72.39%-3.74K | 74.01%-18.93K | 85.99%-10K |
| Net investment purchase and sale | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --22.5K | --0 |
| Net other investing changes | ---3.5K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -45.83%-3.5K | 136.47%7.03K | --0 | -2,214.81%-75.54K | -401.22%-50.12K | -125.33%-2.4K | -297.01%-19.28K | -141.77%-3.74K | 104.90%3.57K | 85.99%-10K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Cash from discontinued financing activities | ||||||||||
| Net cash flow | ||||||||||
| Beginning cash position | -90.79%11.81K | -88.78%21.46K | -82.40%49.33K | -29.14%280.28K | -72.17%83.23K | -59.82%128.17K | -43.68%191.19K | -29.14%280.28K | 9.48%395.54K | 28.18%299.06K |
| Current changes in cash | 250.41%67.59K | 84.69%-9.65K | 68.72%-27.87K | -100.38%-230.95K | -80.56%-33.91K | -125.34%-44.94K | -208.07%-63.02K | -58.86%-89.09K | -436.62%-115.26K | -111.58%-18.78K |
| End cash Position | -4.61%79.4K | -90.79%11.81K | -88.78%21.46K | -82.40%49.33K | -82.40%49.33K | -72.17%83.23K | -59.82%128.17K | -43.68%191.19K | -29.14%280.28K | -29.14%280.28K |
| Free cash from | 58.80%-18.51K | 73.53%-16.68K | 68.72%-27.87K | -67.65%-230.95K | -80.56%-33.91K | -125.34%-44.94K | -208.07%-63.02K | -13.38%-89.09K | 31.79%-137.76K | 74.61%-18.78K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.